Octyl gallate

We are Octyl gallate CAS:1034-01-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Octyl gallate
CAS.NO:1034-01-1
Synonyms:Gallic Acid n-Octyl Ester; octyl 3,4,5-trihydroxybenzoate; n-Octyl Gallate; 3,4,5-Trihydroxy benzoic acid octyl ester;
 
Physical and Chemical Properties:
Density:1.185;
Melting point:101-104oC;
Boiling point:482.9oC;
Flash point:177.1oC;
Index of Refraction:1.552;

Molecular Formula:C15H22O5
Molecular Weight:282.33200
 
Specification:

Specification

Industrial grade

Pharmaceutical grade

Food grade

Quality standard

Factory standard

BP2009

Factory standard

Content

≥99%

≥99.5%

≥99.5%

Loss on drying

≤0.5%

≤0.5%

≤0.5%

Residue on ignition

≤0.1%

≤0.1%

≤0.1%

APHA

≤180

≤50

≤0.1%

Water solubility

clear

clear

clear

 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 

Octyl gallate


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS:503615-03-0 According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).N-acetil-DL-leucina CAS:99-15-0 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.121012-73-5 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.

Related Products
Product Name
3-(tert-Butyldimethylsilyloxy)glutaric anhydride View Details
2,3-Dimethyl-2H-indazol-6-amine View Details
4-Bromo-2-fluorotoluene View Details
18-crown-6 manufacturer 2-Chlorotoluene manufacturer 1-Methoxy-2-propanol manufacturer 3-Bromoaniline manufacturer 2-Amino-5-bromoisonicotinic acid manufacturer